Patents by Inventor David J. Blythin

David J. Blythin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5011845
    Abstract: Compounds of the formula ##STR1## wherein R.sup.5 represents C.sub.1 to C.sub.6 -alkyl or the group--(CH.sub.2).sub.n --Z--(CH.sub.2).sub.m --Ar wherein Z represents O, S or --CH.sub.2 --and Ar is phenyl, optionally substituted by one or two groups selected from the group consisting of hydrogen, C.sub.1 to C.sub.6 -alkyl, C.sub.1 to C.sub.6 -alkoxy, Cl,F,Br,I,NO.sub.2, CF.sub.3, CN, R.sup.6 -S(O).sub.x, R.sup.7 --CO--,(R.sup.8 R.sup.9)NCO-and phenyl, wherein x is 0, 1 or 2, and each R.sup.6, R.sup.7, R.sup.8 and R.sup.9 is independently C.sub.1 to C.sub.6 alkyl or two adjacent groups on Ar may form together an additional fused benzenoid ring; n and m independently represent integers of from 1 to 8; and ring Q represents one of the rings Q.sub.1, Q.sub.2, Q.sub.3 or Q.sub.4 below: ##STR2## X is N or C--R.sup.1 ; Y is N or C--R.sup.4 ;W represents O or S;each of R.sup.1, R.sup.2, R.sup.3 and R.sup.4 is independently selected from hydrogen, C.sub.1 to C.sub.6 -alkyl, C.sub.1 to C.sub.6 -alkoxy, Cl,F,Br,I,NO.sub.
    Type: Grant
    Filed: June 13, 1990
    Date of Patent: April 30, 1991
    Assignee: Schering Corporation
    Inventors: David J. Blythin, Ho-Jane Shue, Ashit K. Ganguly
  • Patent number: 4996212
    Abstract: Tricyclic pyrrolo naphthyridinone compounds are disclosed, which are useful as antiinflammatory and anti-hyperprolferative agents.
    Type: Grant
    Filed: December 21, 1989
    Date of Patent: February 26, 1991
    Assignee: Schering Corporation
    Inventors: Timothy Duelfer, David J. Blythin
  • Patent number: 4916131
    Abstract: 1-Substituted naphthyridines and pyrido-pyrazines are disclosed which are useful in treating allergic reactions, inflammation, peptic ulcers and hyperproliferative skin diseases and in suppressing the immune response in mammals. Pharmaceutical compositions and methods of treatment employing such compounds are also disclosed.
    Type: Grant
    Filed: July 20, 1988
    Date of Patent: April 10, 1990
    Assignee: Schering Corporation
    Inventors: David J. Blythin, Marvin I. Siegel, Sidney R. Smith
  • Patent number: 4902693
    Abstract: Esters, acetal ethers, thioethers and nitrogen substituted derivatives of certain bicyclic compounds are disclosed which are useful as anti-allergic, anti-inflammatory and/or cytoprotective agents and in treatment of hyperproliferative skin disease. Pharmaceutical compositions and methods of treatment employing such compounds are also disclosed.
    Type: Grant
    Filed: July 22, 1988
    Date of Patent: February 20, 1990
    Assignee: Schering Corporation
    Inventors: David J. Blythin, Ho-Jane Shue
  • Patent number: 4897397
    Abstract: Certain aryl-alkynoic, alkenoic and alkanoic acids and derivatives and their use in treating inflammation, allergy and hyperproliferative skin disease are disclosed.
    Type: Grant
    Filed: December 16, 1988
    Date of Patent: January 30, 1990
    Assignee: Schering Corporation
    Inventors: Neng Y. Shih, David J. Blythin
  • Patent number: 4866061
    Abstract: Aryl-substituted naphthyridines and pyridopyrazines are disclosed which are useful in treating allergic reactions, inflammation, peptic ulcers and/or hyperproliferative skin disease. Pharmaceutical compositions and methods of treatment employing such compounds are also disclosed.
    Type: Grant
    Filed: May 12, 1988
    Date of Patent: September 12, 1989
    Assignee: Schering Corporation
    Inventors: David J. Blythin, Ho-Jane Shue
  • Patent number: 4859669
    Abstract: Tricyclic pyrrolo naphthyridinone compounds and tricyclic pyrrolo pyrido pyrazines are disclosed, which are useful as antiinflammatory and anti-hyperproliferative agents.
    Type: Grant
    Filed: December 23, 1987
    Date of Patent: August 22, 1989
    Assignee: Schering Corporation
    Inventors: Timothy Duelfer, David J. Blythin
  • Patent number: 4794116
    Abstract: Esters, acetal ethers, thioethers and nitrogen substituted derivatives of certain bicyclic compounds are disclosed which are useful as anti-allergic, anti-inflammatory and/or cytoprotective agents and in treatment of hyperproliferative skin disease. Pharmaceutical compositions and methods of treatment employing such compounds are also disclosed.
    Type: Grant
    Filed: July 22, 1987
    Date of Patent: December 27, 1988
    Assignee: Schering Corporation
    Inventors: David J. Blythin, Ho-Jane Shue
  • Patent number: 4782067
    Abstract: Zwitterionic bicyclic compounds are disclosed which are useful as anti-allergic, anti-inflammatory and/or cytoprotective agents and in the treatment of hyperproliferative skin disease. Pharmaceutical compositions and methods of treatment employing such compounds are also disclosed.
    Type: Grant
    Filed: July 22, 1987
    Date of Patent: November 1, 1988
    Assignee: Schering Corporation
    Inventors: David J. Blythin, Ho-Jane Shue
  • Patent number: 4775686
    Abstract: 1-Substituted naphthyridines and pyrido-pyrazines are disclosed which are useful in treating allergic reactions, inflammation, peptic ulcers and hyperproliferative skin diseases and in suppressing the immune response in mammals. Pharmaceutical compositions and methods of treatment employing such compounds are also disclosed.
    Type: Grant
    Filed: December 18, 1986
    Date of Patent: October 4, 1988
    Assignee: Schering Corporation
    Inventors: David J. Blythin, Marvin I. Siegel, Sidney R. Smith
  • Patent number: 4775524
    Abstract: A method of treating a mammal for hyperproliferative skin disease is disclosed, using substituted heterospiro pyridine derivatives.
    Type: Grant
    Filed: December 5, 1986
    Date of Patent: October 4, 1988
    Assignee: Schering Corporation
    Inventor: David J. Blythin
  • Patent number: 4760073
    Abstract: Aryl-substituted naphthyridines and pyridopyrazines are disclosed which are useful in treating allergic reactions, inflammation, peptic ulcers and/or hyperproliferative skin disease. Pharmaceutical compositions and methods of treatment employing such compounds are also disclosed.
    Type: Grant
    Filed: December 23, 1986
    Date of Patent: July 26, 1988
    Assignee: Schering Corporation
    Inventors: David J. Blythin, Ho-Jane Shue
  • Patent number: 4740511
    Abstract: A method of treating hyperproliferative skin disease with substituted quinoline, [1,5]- and [1,8]- naphthyridine and pyrido[2,3-b]pyrazine derivatives is disclosed. The compounds are also anti-allergic, anti-inflammatory and cytoprotective agents. Methods for their preparation and use are disclosed.
    Type: Grant
    Filed: February 18, 1987
    Date of Patent: April 26, 1988
    Assignee: Schering Corporation
    Inventor: David J. Blythin
  • Patent number: 4684727
    Abstract: Zwitterionic bicyclic compounds are disclosed which are useful as anti-allergic, anti-inflammatory and/or cytoprotective agents. Pharmaceutical compositions and methods of treatment employing such compounds are also disclosed.
    Type: Grant
    Filed: July 29, 1985
    Date of Patent: August 4, 1987
    Assignee: Schering Corporation
    Inventors: David J. Blythin, Ho-Jane Shue
  • Patent number: 4680298
    Abstract: Substituted quinoline, [1,5]- and [1,8]-naphthyridine and pyrido[2,3-b]pyrazine derivatives are anti-allergic, anti-inflammatory and cytoprotective agents. Methods for their preparation and use are disclosed.
    Type: Grant
    Filed: April 9, 1984
    Date of Patent: July 14, 1987
    Assignee: Schering Corporation
    Inventor: David J. Blythin
  • Patent number: 4680297
    Abstract: Substituted quinoline, [1,5]- and [1,8]-naphthyridine and pyrido [2,3-b]pyrazine derivatives are useful positive inotropic agents.
    Type: Grant
    Filed: June 20, 1985
    Date of Patent: July 14, 1987
    Assignee: Schering Corporation
    Inventors: David J. Blythin, Robert W. Watkins
  • Patent number: 4652564
    Abstract: Substituted spiro pyridine derivatives are anti-allergic and anti-inflammatory agents. They are also useful for the treatment of peptic ulcers.Methods for their preparation and use are disclosed.
    Type: Grant
    Filed: December 14, 1983
    Date of Patent: March 24, 1987
    Assignee: Schering Corporation
    Inventor: David J. Blythin
  • Patent number: 4632923
    Abstract: Substituted heterospiro pyridine derivatives are anti-allergic and anti-inflammatory agents. They are also useful for the treatment of peptic ulcers.Methods for their preparation and use are disclosed.
    Type: Grant
    Filed: August 15, 1984
    Date of Patent: December 30, 1986
    Assignee: Schering Corporation
    Inventor: David J. Blythin
  • Patent number: 4569936
    Abstract: Substituted 9H-8-oxo-pyrimido[2,1-f]purine-2,4-diones their tautomers and salts are anti-inflammatory agents.Methods for their preparation and use are described.
    Type: Grant
    Filed: October 21, 1983
    Date of Patent: February 11, 1986
    Assignee: Schering Corporation
    Inventor: David J. Blythin
  • Patent number: 4297355
    Abstract: This invention relates to (1H,3H,5H)-(1)-benzopyrano-(2,3-d)-pyrimidine-4-one-2-thiones, to pharmaceutically acceptable salts thereof, to the methods for their preparation and to their use as agents in the prophylactic treatment of allergic conditions such as asthma, allergic rhinitis, urticaria and ulcerative colitis.
    Type: Grant
    Filed: November 15, 1979
    Date of Patent: October 27, 1981
    Assignee: Schering Corporation
    Inventor: David J. Blythin